Fig 1.
Schema of patient inclusion criteria.
Fig 2.
Study timeline.
Table 1.
Baseline characteristics of all included patients.
Fig 3.
Kaplan–Meier curve representing association of OS with pre-treatment NLR (fig 3A) and post-treatment NLR (fig 3B).
Fig 4.
Kaplan–Meier curve representing association of OS with post-treatment ALC (fig 4A), post-treatment ANC (fig 4B), pre-treatment ALC (fig 4C) and pre-treatment ANC (fig 4D).
Table 2.
Summary statistics for hematological parameter among patients with objective response (CR, PR) as compared to non-responders (PD).